A detailed history of Intrust Bank Na transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Intrust Bank Na holds 2,682 shares of AXSM stock, worth $238,778. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,682
Previous 2,940 8.78%
Holding current value
$238,778
Previous $234,000 8.12%
% of portfolio
0.02%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$65.72 - $80.5 $16,955 - $20,769
-258 Reduced 8.78%
2,682 $215,000
Q1 2024

May 09, 2024

BUY
$69.39 - $97.64 $6,522 - $9,178
94 Added 3.3%
2,940 $234,000
Q4 2023

Feb 05, 2024

SELL
$57.42 - $83.61 $20,097 - $29,263
-350 Reduced 10.95%
2,846 $226,000
Q3 2023

Nov 13, 2023

BUY
$69.25 - $82.21 $10,387 - $12,331
150 Added 4.92%
3,196 $223,000
Q2 2023

Aug 10, 2023

BUY
$58.41 - $90.35 $177,916 - $275,206
3,046 New
3,046 $218,000
Q4 2022

Feb 10, 2023

BUY
$39.94 - $79.72 $138,192 - $275,831
3,460 New
3,460 $266,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.82B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Intrust Bank Na Portfolio

Follow Intrust Bank Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Intrust Bank Na with notifications on news.